ICU Medical (ICUI)
(Delayed Data from NSDQ)
$118.35 USD
+0.37 (0.31%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $118.23 -0.12 (-0.10%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ICUI 118.35 +0.37(0.31%)
Will ICUI be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ICUI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ICUI
Implied Volatility Surging for ICU Medical (ICUI) Stock Options
ICU Medical (ICUI) Q1 Earnings and Revenues Surpass Estimates
ICUI: What are Zacks experts saying now?
Zacks Private Portfolio Services
BellRing Brands (BRBR) Q2 Earnings and Revenues Top Estimates
ICON (ICLR) Q1 Earnings Surpass Estimates, Margins Expand
Align Technology (ALGN) Q1 Earnings Top, 2024 Sales View Up
Other News for ICUI
ICU Medical - Stabilization Is In Sight, But The Road Back Is Difficult
Staar Surgical Co's Meteoric Rise: Unpacking the 21% Surge in Just 3 Months
Needham starts ICU Medical at hold, cites limited revenue growth
ICU Medical initiated with neutral view at Needham, here's why
ICU Medical: Hold Rating Affirmed Amid Balanced Growth Prospects and Valuation